24 October 2017 - From 1 November 2017 dexamethasone implants (brand name Ozurdex) will be funded for eligible people with ...
13 October 2016 - PHARMAC is pleased to announce the approval of an agreement with Allergan for the listing of ...
4 October 2017 - PHARMAC is seeking feedback on a proposal to list a range of medical thermometer and venous thromboembolism ...
1 October 2017 - The October 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
15 September 2017 - PHARMAC is seeking feedback on a proposal to list dexamethasone 700 mcg ocular implants (Ozurdex) through ...
15 September 2017 - PHARMAC is seeking feedback on a proposal to fund the zoster vaccine (Zostavax) for the prevention ...
11 September 2017 - Eligible people will now be able to receive ferric carboxymaltose iron infusions in some general practitioners’ ...
4 September 2017 - PHARMAC is pleased to announce the approval of an agreement with GSK for the supply of ...
1 September 2017 - The September 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
1 August 2017 - The August 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
21 July 2017 - PHARMAC proposes to continue to fund the Habitrol brand of nicotine gum, lozenges and patches supplied ...
20 July 2017 - PHARMAC proposes two key changes to the funding of aripiprazole tablets, an antipsychotic medicine for use ...
6 July 2017 - PHARMAC is pleased to announce the approval of an amendment to the suture agreement with Johnson ...
1 July 2017 - The July 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
21 June 2017 - PHARMAC is pleased to announce the approval of an agreement with ArjoHuntleigh for the supply of ...